Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations- no definite conclusions

Cobi Zee; PCM Koper; LCHW Lutgens; Curt Burger

doi:10.1080/02656730110083738

Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations- no definite conclusions

Cobi Zee, PCM Koper, LCHW Lutgens, Curt Burger

Research output: Contribution to journal › Article › Academic › peer-review

15 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	19-24
Number of pages	6
Journal	International Journal of Hyperthermia
Volume	18
Issue number	1
DOIs	https://doi.org/10.1080/02656730110083738
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/02656730110083738

http://hdl.handle.net/1765/66199

Cite this

Zee, C., Koper, PCM., Lutgens, LCHW., & Burger, C. (2002). Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations- no definite conclusions. International Journal of Hyperthermia, 18(1), 19-24. https://doi.org/10.1080/02656730110083738

Zee, Cobi ; Koper, PCM ; Lutgens, LCHW et al. / Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations- no definite conclusions. In: International Journal of Hyperthermia. 2002 ; Vol. 18, No. 1. pp. 19-24.

@article{ba0f4280008242799d52eae2deb15b6d,

title = "Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations- no definite conclusions",

author = "Cobi Zee and PCM Koper and LCHW Lutgens and Curt Burger",

year = "2002",

doi = "10.1080/02656730110083738",

language = "Undefined/Unknown",

volume = "18",

pages = "19--24",

journal = "International Journal of Hyperthermia",

issn = "0265-6736",

publisher = "Informa Healthcare",

number = "1",

}

Zee, C, Koper, PCM, Lutgens, LCHW & Burger, C 2002, 'Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations- no definite conclusions', International Journal of Hyperthermia, vol. 18, no. 1, pp. 19-24. https://doi.org/10.1080/02656730110083738

Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations- no definite conclusions. / Zee, Cobi; Koper, PCM; Lutgens, LCHW et al.

In: International Journal of Hyperthermia, Vol. 18, No. 1, 2002, p. 19-24.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations- no definite conclusions

AU - Zee, Cobi

AU - Koper, PCM

AU - Lutgens, LCHW

AU - Burger, Curt

PY - 2002

Y1 - 2002

U2 - 10.1080/02656730110083738

DO - 10.1080/02656730110083738

M3 - Article

VL - 18

SP - 19

EP - 24

JO - International Journal of Hyperthermia

JF - International Journal of Hyperthermia

SN - 0265-6736

IS - 1

ER -

Zee C, Koper PCM, Lutgens LCHW, Burger C. Point-counterpoint: what is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations- no definite conclusions. International Journal of Hyperthermia. 2002;18(1):19-24. doi: 10.1080/02656730110083738